Edesa Biotech, Inc.EDSANASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank21
Studio
Year-over-Year Change

Free cash flow yield

Latest
-52.22%
↓ 46% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
-35.65%
Historical baseline
PeriodValueYoY Change
2025-52.22%-51.9%
2024-34.37%+34.7%
2023-52.65%+42.1%
2022-91.01%-493.2%
2021-15.34%-112.2%
2020-7.23%+57.5%
2019-16.99%+5.1%
2018-17.90%+72.7%
2017-65.47%-1878.0%
2016-3.31%-